Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study

BACKGROUND: The World Health Organization recommends dolutegravir (DTG) as the for first-line and second-line antiretroviral therapy (ART) worldwide. However, little is known about the acceptability and tolerability of DTG-based ART at routine points-of-care in Uganda. We set out to explore the perc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakumumpa, Henry, Kitutu, Freddy Eric, Ndagije, Helen Byomire, Diana, Nakitto-Kesi, Ssanyu, Jacquellyn Nambi, Kiguba, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650263/
https://www.ncbi.nlm.nih.gov/pubmed/34876050
http://dx.doi.org/10.1186/s12879-021-06933-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650263/
https://www.ncbi.nlm.nih.gov/pubmed/34876050
http://dx.doi.org/10.1186/s12879-021-06933-8

Ejemplares similares